Debt-to-equity of INOVIO PHARMACEUTICALS, INC. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
INOVIO PHARMACEUTICALS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • INOVIO PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 141%, a 238% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

INOVIO PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 141% +99% +238% 30 Sep 2025
Q2 2025 69% +29% +72% 30 Jun 2025
Q1 2025 52% +12% +31% 31 Mar 2025
Q4 2024 45% +6.6% +17% 31 Dec 2024
Q3 2024 42% -1.2% -2.9% 30 Sep 2024
Q2 2024 40% -4.2% -9.5% 30 Jun 2024
Q1 2024 40% -8.9% -18% 31 Mar 2024
Q4 2023 38% -5.7% -13% 31 Dec 2023
Q3 2023 43% +6.9% +19% 30 Sep 2023
Q2 2023 45% +16% +56% 30 Jun 2023
Q1 2023 49% +28% +138% 31 Mar 2023
Q4 2022 44% +27% +156% 31 Dec 2022
Q3 2022 36% +20% +127% 30 Sep 2022
Q2 2022 29% +10% +54% 30 Jun 2022
Q1 2022 21% -13% -39% 31 Mar 2022
Q4 2021 17% -35% -67% 31 Dec 2021
Q3 2021 16% -79% -83% 30 Sep 2021
Q2 2021 19% -144% -89% 30 Jun 2021
Q1 2021 34% -153% -82% 31 Mar 2021
Q4 2020 52% -228% -81% 31 Dec 2020
Q3 2020 95% -55% -37% 30 Sep 2020
Q2 2020 162% +69% +74% 30 Jun 2020
Q1 2020 187% +127% +210% 31 Mar 2020
Q4 2019 280% +237% +550% 31 Dec 2019
Q3 2019 150% +112% +293% 30 Sep 2019
Q2 2019 93% +58% +167% 30 Jun 2019
Q1 2019 60% +27% +79% 31 Mar 2019
Q4 2018 43% +11% +36% 31 Dec 2018
Q3 2018 38% +4.3% +13% 30 Sep 2018
Q2 2018 35% -1.3% -3.6% 30 Jun 2018
Q1 2018 34% -1.1% -3.2% 31 Mar 2018
Q4 2017 32% +1.8% +6.2% 31 Dec 2017
Q3 2017 34% +8.4% +33% 30 Sep 2017
Q2 2017 36% +14% +61% 30 Jun 2017
Q1 2017 35% +16% +84% 31 Mar 2017
Q4 2016 30% +13% +76% 31 Dec 2016
Q3 2016 26% +9.8% +62% 30 Sep 2016
Q2 2016 22% +8.2% +57% 30 Jun 2016
Q1 2016 19% +3% +19% 31 Mar 2016
Q4 2015 17% +0.19% +1.1% 31 Dec 2015
Q3 2015 16% -6.9% -30% 30 Sep 2015
Q2 2015 14% -14% -50% 30 Jun 2015
Q1 2015 16% -23% -59% 31 Mar 2015
Q4 2014 17% -38% -69% 31 Dec 2014
Q3 2014 23% -23% -50% 30 Sep 2014
Q2 2014 28% -18% -39% 30 Jun 2014
Q1 2014 39% +0.6% +1.6% 31 Mar 2014
Q4 2013 55% +19% +51% 31 Dec 2013
Q3 2013 46% +10% +30% 30 Sep 2013
Q2 2013 47% +16% +54% 30 Jun 2013
Q1 2013 38% +11% +39% 31 Mar 2013
Q4 2012 36% 31 Dec 2012
Q3 2012 35% 30 Sep 2012
Q2 2012 30% 30 Jun 2012
Q1 2012 27% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.